Introduction: Staphylococcus epidermidis is one of the most frequent causes of biofilm-associated infections on indwelling medical devices. With the emergence of methicillin-resistant S. epidermidis (MRSE), there is an urgent need to discover novel active agents against a range of Gram-positive pathogens. We screened the clinical isolates of S. epidermidis for susceptibility/resistance against commonly prescribed antibiotics. Furthermore, we tested some natural agents alone and in combination with antibiotics to find possible synergistic antimicrobial effects. Methodology: S. epidermidis clinical isolates were screened for susceptibility/resistance against vancomycin, erythromycin, tetracycline, chloramphenicol, ampicillin, ofloxacin, cephalexin, and gentamicin using the Kirby-Bauer disk diffusion method. The antimicrobial potential of Camellia sinensis, Juglans regia, and Hippophae rhamnoides alone and in combination with antibiotics were examined using the disk diffusion method, where the antimicrobial potential activity was measured in terms of formation of zones of inhibition. Results: Most S. epidermidis isolates were found to be resistant to one or more antibiotics. Gentamycin and ofloxacin were found to be the most effective antibiotics against S. epidermidis isolates. Extracts of Hippophae rhamnoides, Juglans regia, and Camellia sinensis were found to be equally effective against S. epidermidis isolates. In combination with antibiotics, these extracts exhibited appreciable synergistic activity; the highest synergistic activity was observed with erythromycin and cephalexin. In the case of cephalexin, a reversion in resistance was observed. Conclusions: The plant extracts used in the study exhibited additive and synergistic antibacterial activity against S. epidermidis, hence providing an effective alternative to deal with the problem of multidrug resistance.
Introduction
The growing use of indwelling medical devices such as intravascular catheters, artificial heart valves, and orthopedic implants has resulted in a significant increase in the number of device-related infections [1] . Staphylococci, above all Staphylococcus aureus and Staphylococcus epidermidis, are the most frequent causes of biofilm-associated infections on indwelling medical devices, with S. epidermidis representing up to 75% of all clinical isolates in some cases [2] [3] [4] .
S. epidermidis that has developed the same bacterial resistance as S. aureus and is known as methicillin-resistant S epidermidis (MRSE). In recent years, the prevalence of multidrug-resistant methicillin-resistant Staphylococcus aureus (MRSA) strains exhibiting resistance to other antibiotics such as aminoglycosides, minocycline, and fluoroquinolones has also increased [5] [6] [7] . Some studies have found the drug resistance rates for S. epidermidis to be higher than 90% of all samples tested [8] .
One of the major mechanisms that enable S. epidermidis to cause serious health problems and develop antibiotic resistance is its ability to adhere to surfaces and grow a biofilm [9, 10] .
The rapid increase in the prevalence of multidrugresistant Gram-positive bacteria has created an urgent need to discover novel active agents against a range of Gram-positive pathogens. In this study, we screened the clinical isolates of S. epidermidis from Pakistan for susceptibility/resistance against commonly prescribed antibiotics for these infections. Additionally, we analyzed some natural agents previously shown to exhibit antimicrobial and antibiofilm activity against Pseudomonas and Mycobacterium species [11, 12] , for their antimicrobial activity against S. epidermidis. These natural agents were tested alone and in combination with antibiotics to observe possible synergistic antimicrobial effects.
Methodology

S. epidermidis isolates and antibiogram development
Thirty-six S. epidermidis isolates, obtained from pus/wounds (IIDRL-SEP/W-1 to IIDRL-SEP/W-36) or blood infections (IIDRL-SEB-1 to IIDRL-SEB-10) were used in this study. The isolates were screened for susceptibility/resistance against eight commonly prescribed antibiotics (vancomycin, erythromycin, tetracycline, chloramphenicol, ampicillin, ofloxacin, cephalexin, and gentamicin) using the Kirby-Bauer disk diffusion method as described previously [13] . Commercially available standard antibiotic disks of standardized concentrations (Oxoid, Basingstoke, UK) were used in antibiotic resistance/susceptibility testing.
Antimicrobial activity of plant extracts
Aqueous plant extracts (5%) were prepared by soaking 2.5 g dried berries, dried barks, and dried leaves of Hippophae rhamnoides, Juglans regia, and Camellia sinensis, respectively, in 50 mL of autoclaved distilled water and boiling for three minutes, thrice, with two-minute intervals between each boiling time. Subsequently, the extract or supernatant was collected in a separate 50 mL tube and centrifuged for 15 minutes at 5,000 rpm. The clear supernatant obtained was collected and filter sterilized using a 0.2 um filter (micropore filters), and was stored at -20°C. For this study, extracts no older than one week were used; otherwise, fresh extracts were prepared.
The antimicrobial potential of Camellia sinensis, Juglans regia, and Hippophae rhamnoides aqueous extracts (5%) against S. epidermidis isolate IIDRL-SEP/W-10 and S. epidermidis strain ATCC 12228 was examined using the disk diffusion method as described previously [11] .
Evaluation of synergistic activity of plant extracts with antibiotics
Synergistic activity of aqueous extracts of Camellia sinensis, Juglans regia, and Hippophae rhamnoides and the eight above-mentioned antibiotics was examined using the disk diffusion method. Briefly, each plant extract was incorporated into a separate Müller-Hinton agar (MHA) plate to achieve a final concentration of 1 mg/mL. Next, a lawn of 0.5 McFarland matched IIDRL-SEP/W-10 culture was prepared on MHA plates, using sterile cotton swabs. Commercial antibiotic disks (Oxoid) were placed at appropriate distances on the lawn, and plates were incubated for 24-48 hours at 37°C. The synergistic activity was measured in terms of formation of zones of inhibition in millimeters. The difference between antimicrobial activities of antibiotics alone and in combination with natural agents was tested using oneway analysis of variance (ANOVA) with Tukey's multiple correction [14] , using Graphpad software.
Results
Antibiotic resistance/susceptibility profile of S. epidermidis isolates
The antibiotic resistance/susceptibility profile of S. epidermidis isolates revealed that most of the isolates were resistant to one or more of the tested antibiotics ( Figure 1) . Most of the isolates were resistant to erythromycin, ampicillin, tetracycline, and chloramphenicol (Figure 1 ), while gentamycin and ofloxacin were found to be the most effective antibiotics (Figure 1 ).
Synergistic activity of plant extracts in combination with antibiotics against S. epidermidis
Aqueous extracts of Hippophae rhamnoides, Juglans regia, and Camellia sinensis were found to be equally effective against S. epidermidis isolate IIDRL-SEP/W-10 ( Figure 2 , grey bars) as well as against S. epidermidis reference strain ATCC 12228 (data not shown).
These aqueous extracts together with antibiotics exhibited appreciable synergistic activity (Figure 2 ). The highest activity was observed for erythromycin and cephalexin, where > 50% increase in antimicrobial activity was observed as compared to antibiotics alone (p < 0.001; Figure 2 ). In the case of cephalexin, a reversion in resistance was observed, where an isolate previously resistant to cephalexin alone was found to be susceptible to a cephalexin-plant extract combination (Figure 2) . However, no change in susceptibility was observed for ampicillin.
Discussion
Our study showed that the majority of S. epidermidis isolates were resistant to one or more tested antibiotics, which supports earlier studies showing a high rate of resistance in S. epidermidis against quinolones and a moderate resistance rate to second-generation and third-generation cephalosporins [15] . In our study, we found gentamycin and ofloxacin to be the most effective antibiotics against our S epidermidis isolates. This information can be helpful for practicing ophthalmologists and dermatologists because S. epidermidis has been the most common causative pathogen, responsible for endophthalmitis associated with intraocular foreign bodies [16, 17] , acne, and burn-associated infections.
Our report appears to be the first to report synergistic antibacterial effect of Hippophae rhamnoides and antibiotics against S. epidermidis. Hippophae rhamnoides is known to have antibacterial and antioxidant effects, which are mediated by phenols and flavonoid contents. [18] . Phenolic rich fraction of Hippophae rhamnoides has been found to contain gallic acid, rutin, quercetin-3-galactoside, quercetin-3-glucoside, myricetin, quercetin, kaempferol, and isorhamnetin. These constituents have also proven to have potent antibacterial and antioxidant activity against Escherichia coli, Salmonella typhi, Shigella dysenteriae, Streptococcus pneumoniae, and Staphylococcus aureus [19] .
We also found that the addition of Juglans regia to the antibiotics resulted in increased activity against S. epidermidis. Significant synergistic effects were observed when erythromycin was combined with the plant extracts (Figure 2) . It has been shown that Juglans regia leaf extracts have an inhibitory effects on the acne lesions caused by S. epidermidis, possibly because of their anti-inflammatory properties [20] . Juglans regia contains α-pinene, β-pinene, β-caryophyllene, germacrene D, and limonene. These constituents are known to exhibit broad-spectrum antibacterial activity against all the bacterial strains, especially against Gram-positive bacteria, including S. epidermidis [21] .
Our study is in agreement with earlier studies showing strong antimicrobial potential of Camellia sinensis against S. epidermidis [22, 23] . Camellia sinensis is known for its therapeutic properties, especially anti-inflammatory and anti-microbial. Although the anti-microbial properties of Camellia sinensis are known, its role against bacterial strains involved in skin infections is not well understood. The main active ingredient of Camellia sinensis is an acidic polysaccharide CS-F2, a pectin-type polysaccharide with a molecular weight of approximately 8.0 x 10 4 Da, which has been characterized by its anti-adhesive effects against pathogenic bacteria, most notably against Helicobacter pylori, Propionibacterium acnes, and S. aureus. Interestingly, CS-F2 showed no inhibitory effects against S. epidermidis [24] , because Camellia sinensis has been shown to exert a selective anti-adhesive effect against certain pathogenic bacteria with no adverse effects against beneficial or commensal bacteria [25] .
The other possible mechanism by which these natural agents might be exerting their antimicrobial effect or synergistic effect with antibiotics is through inhibition of bacterial efflux pumps [26] . Bacteria use efflux pumps as a self-defense mechanism to remove antibiotics from the cell. The activity through efflux pumps results in sub-lethal drug concentrations at the active site that often predisposes the organism to the development of high-level resistance against antimicrobial agents [26] . Several studies have reported the crucial role of phytochemistry in the search for effective efflux pumps inhibitors (EPIs), especially against Gram-positive bacteria such as S. aureus and S. epidermidis. The activity of plantderived EPIs is attributed to their chemical properties, including flavones, isoflavones, acylated glycosides, porphyrin phaeophorbide A, or kaempferol rhamnoside [26] . The structures of the plant-derived EPIs have been exploited to produce several synthetic EPIs exhibiting inhibitory activity at micrometer concentrations [26] .
Conclusions
Antibiotics have been effective in treating infectious diseases, but resistance to these drugs has led to the emergence of new, and the re-emergence of old, infectious diseases. One strategy employed to overcome these resistance mechanisms is the use of combination of drugs, such as beta-lactams together with beta-lactamase inhibitors. We have shown that plant extracts have exhibited additive and synergistic antibacterial activity against Staphylococcus epidermidis. Hence, this provides an effective alternate way to deal with the problem of multidrug resistance.
